Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
INSPIRE
2 other identifiers
interventional
586
1 country
2
Brief Summary
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Apr 2025
Typical duration for not_applicable chronic-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2023
CompletedFirst Posted
Study publicly available on registry
December 27, 2023
CompletedStudy Start
First participant enrolled
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
April 13, 2026
April 1, 2026
2.3 years
August 13, 2023
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Pain Intensity and Interference on the 11-point Pain, Enjoyment of Life, and General Activity Scale (PEG)
The PEG Pain Screening Tool is a validated, self-reported 3-question survey assessing pain severity, the extent to which pain interferes with enjoyment of life, and the extent to which pain interferes with general activity. Possible scores for each question range from 0 (no pain, no interference) to 10 (worst possible pain, worst possible interference). The average of scores from the three questions yields the PEG score. Change = (PEG score at time point - PEG score at baseline)
Baseline, 3mo, 6mo, 12mo
Secondary Outcomes (14)
Change from Baseline in Physical Functioning on the 5-point PROMIS Physical Function Short Form 6b
Baseline, 3mo, 6mo, 12mo
Change from Baseline in Sleep Disturbance and Sleep Duration on the 5-point PROMIS Sleep Disturbance Short Form 6a
Baseline, 3mo, 6mo, 12mo
Change from Baseline in Fear and Anxiety about Pain on the 5-point Pain Catastrophizing Scale Short Form 6
Baseline, 3mo, 6mo, 12mo
Change from Baseline in Self-reported Depressive Symptoms on the 4-point Patient Health Questionnaire - 9 (PHQ-9)
Baseline, 3mo, 6mo, 12mo
Change from Baseline in Self-reported Anxiety Symptoms on the 4-point General Anxiety Scale (GAD-7)
Baseline, 3mo, 6mo, 12mo
- +9 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALThe INSPIRE chronic pain management system has three primary components: 1) a patient facing smartphone app that collects and interprets a comprehensive intake and patient reported outcomes (PROs), provides health education, and a tailored, modular self-management program that includes cognitive-behavioral therapy (CBT), physical therapy (PT), and mindfulness-based interventions (MBI), 2) a weekly telehealth visit with a pain coach that uses the PRO data and module engagement measures to guide the visit, and 3) enhanced primary care coordination achieved through pain coaching notes and alerts integrated into the electronic health record (EHR).
Control
NO INTERVENTIONControl participants will receive educational materials about chronic pain and full workbook with non-pharmacologic strategies.
Interventions
Blended CBT, mindfulness, and movement delivered through a mobile app and supported by a weekly telehealth pain management coach.
Eligibility Criteria
You may qualify if:
- age 18 or older
- speak English, Spanish, or Cantonese
- have a UCSF Health or SFHN medical provider (any type)
- be willing to use a smartphone (iOS or Android - either their own or one provided by the study)
- have chronic, non-malignant pain for at least 3 months
- be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms
You may not qualify if:
- Severe mental illness or other condition preventing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
San Francisco General Hospital
San Francisco, California, 94110, United States
UCSF Adult Primary Care Mt. Zion Clinic
San Francisco, California, 94115, United States
Related Publications (1)
Ristau J, Okobi A, Miller MJ, Cheng J, Deviren S, Schwarz EB, Fairchild T, Tsoh JY, Aguilera A, Zheng-Huang CJ, Satterfield JM. Integrating nonpharmacologic strategies for pain with Inclusion, Respect, and Equity (INSPIRE): a digital health study protocol for a pragmatic multisite randomized controlled trial. Trials. 2026 Jan 8;27(1):109. doi: 10.1186/s13063-025-09402-8.
PMID: 41507957DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Satterfield, PhD
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2023
First Posted
December 27, 2023
Study Start
April 15, 2025
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
This project is part of the Helping to End Addiction Longterm (HEAL) initiative and will use the data sharing platform required for that consortia.